From docking false-positive to active anti-HIV agent.
Barreiro G, Kim JT, Guimaraes CR, Bailey CM, Domaoal RA, Wang L, Anderson KS, Jorgensen WL, J Med Chem, 2007 Nov 1 - link

A molecular docking strategy identifies Eosin B as a non-active site inhibitor of protozoal bifunctional thymidylate synthase-dihydrofolate reductase.
Atreya CE, Johnson EF, Irwin JJ, Dow A, Massimine KM, Coppens I, Stempliuk V, Beverley S, Joiner KA, Shoichet BK, Anderson KS, J Biol Chem, 2003 Apr 18 - link